Low Neighborhood Walkability Increases Risk of Asthma in Kids
Findings among children for both incident asthma and ongoing asthma
The patient-burden and quality of life (QOL) impact of atopic dermatitis (AD) in the United States population is not wellestablished.
New insights into mechanisms should enable strategic improvement of allergen immunotherapy, aiming to make it safer, faster, more effective and able to induce long-term tolerance. We review novel approaches with potential to translate into clinical use.
Contribution of each author
Layperson food allergy management plans commonly stipulate that if epinephrine is used to "immediately call 911 and seek care in the nearest medical facility" for observation. Objective: To evaluate the cost-effectiveness of this strategy, versus a watchful waiting approach before activating emergency medical services (EMS).
CONCLUSIONS: Taking the social perspective, the economic impact of severe asthma in Spain was estimated to be €8554/patient/year. PMID: 30003827 [PubMed - as supplied by publisher]
(MedPage Today) -- Better nutrition linked to better asthma control
Asthma remains a common and serious public health problem affecting 24 million people in the United States (US). The disease accounts for 1.6 million emergency department visits and 10.5 million physician's office visits each year in the US . Asthma prevalence rates are higher among specific populations such as children, females, ethnic minorities, and those living below the poverty level; many of these groups also have higher rates of asthma related morbidity and mortality . African-Americans with asthma experience disproportionate rates of morbidity and mortality compared to Caucasians .
To date, allergen immunotherapy (AIT) is the only treatment that affects the long-term development of allergic rhinoconjunctivitis and induces clinical tolerance primarily by stimulating regulatory T (Treg) cells, attenuating T helper 2 (Th2) responses and synthesis of blocking antibodies1. Conventional AIT with subcutaneous injections, sublingual tablets or drops is effective, but consumes time and resources 2.
After completing her fellowship in allergy and immunology, Dr. X accepted an appointment in an academic position at a tertiary care pediatric hospital. Many of the patients Dr. X sees for evaluation of food allergy have undergone serum specific IgE testing prior to their allergy consultation. As time goes on, Dr. X begins to notice a concerning trend in patients referred from Dr. Y, a primary care provider who has been practicing in the community for over twenty years. Dr. X is worried that many of Dr.
Current guidelines recommend the use of anti-inflammatory agents along with moisturizers for the management of atopic dermatitis (AD).1 This approach is prudent, since co-applications of moisturizers under nursing supervision reduce reliance upon topical steroids in AD management.2,3 Yet, some commonly employed moisturizers could harm the skin, if deployed in settings where the barrier already is compromised,3 as in AD. Here, we will compare the key differences between ubiquitous, over-the-counter moisturizers and preparations formulated specifically to correct the biochemical abnormalities in AD.